PSYCHOTROPIC DRUGS: WHAT YOU NEED TO KNOW & CURRENT TRENDS with Deborah Plachta, M.D., at NYPSI

NEW YORK PSYCHOANALYTIC SOCIETY & INSTITUTE:
Extension Program
247 East 82nd St., between 2nd & 3rd, NY, NY, 10028
212-879-6900
www.psychoanalysis.org
www.nypsi.org

PSYCHOTROPIC DRUGS: WHAT YOU NEED TO KNOW & CURRENT TRENDS
Deborah Plachta, M.D., Tuesdays, 7 – 8:30 pm, November 4- 18, 2014, 3 Classes, Fee $90

Register and/or see Extension Programs click HERE or 212-879-6900

This course highlights the cutting edge of psychopharmacology to acquaint participants with the major trends in diagnosis and medication.The aim is to help the clinician recognize when a treatment could benefit from a psychopharmacology consult or ongoing medication backup. Included are issues of how to approach this with patients/clients, as well as medication side effects and their possible (and impossible) remedies. Topics included are: depression and bipolar illness; anxiety disorder spectrum (e.g., panic states, OCD, body dysmorphic disorder, phobias); psychosis; drugs in pregnancy; sleep disorders.Questions (including case presentations) will be encouraged.

Dr. Deborah Plachta is a member of NYPSI, the American Association of Clinical Psychopharmacology, Assistant Clinical Professor of Psychiatry at Albert Einstein College of Medicine, and is certified by the American Psychoanalytic Association. Psychopharmacology has been a particular focus of hers for many years, during which she has practiced as psychopharmacology backup for a broad range of patients as part of a tertiary referral group.

The Extension Program welcomes mental health professionals, trainees in fields of psychiatry, psychology, and social work, and any members of the community who are interested in psychoanalytic principles.

Educational Objectives: After attending, participants will be able to

1) Recognize biologically-driven syndromes that underlie presenting symptoms and often require medication to resolve.

2) Recognize common side effects of medications, and distinguish them from somaticizing.

3) Assess patient fear and resistance to medication with the aim to improve conflict exploration and allow access to feelings that would otherwise be repressed as too dangerous.

CME credit for physicians:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Psychoanalytic Association and the New York Psychoanalytic Society and Institute. The American Psychoanalytic Association is accredited by the ACCME to provide continuing medical education for physicians.

The American Psychoanalytic Association designates this Live Activity for a maximum of [4.5] AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

IMPORTANT DISCLOSURE INFORMATION FOR ALL LEARNERS: None of the planners and presenters of this CME program have any relevant financial relationships to disclose.

CE credit for psychologists:

Psychologists: New York Psychoanalytic Society & Institute is approved by the American Psychological Association (APA) to sponsor continuing education programs for psychologists. New York Psychoanalytic Society & Institute maintains responsibility for this program and its content.

DISCLOSURE: None of the planners or presenters of this CE program has any relevant financial relationships to disclose.

Persons with disabilities: The building is wheelchair accessible and has an elevator. Please notify the registrar in advance if you require accommodations.

For information about NYPSI training programs please visit us a

www.psychoanalysis.org or www.nypsi.org

Follow NYPSI on Twitter

Follow NYPSI on Facebook

Follow NYPSI on YouTube

Follow NYPSI on LinkedIn